{
  "id": 338,
  "text": "A prospective cohort study showed the crude rate of CIN3 was $0 .7 \\%$ following a single follow up negative cytology, $0 .2 \\%$ following a single negative follow up HPV testing and $0 .1 \\%$ following a negative follow up co-testing in women with HPV-positive ASCUS or any LSIL and less than CIN2 on colposcopy or biopsy over a maximum of 7 years follow up (64).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: A prospective cohort study showed the crude rate of CIN3 was $0 .7 \\%$ following a single follow up negative cytology, $0 .2 \\%$ following a single negative follow up HPV testing and $0 .1 \\%$ following a negative follow up co-testing in women with HPV-positive ASCUS or any LSIL and less than CIN2 on colposcopy or biopsy over a maximum of 7 years follow up (64).\n\n<question>: ",
  "ChatGPT_response_0": "基于潜在队列研究的结果，在接受一次阴性细胞学随访后，CIN3的发病率为0.7％；接受一次阴性HPV测试随访后的发病率为0.2％；而接受阴性综合检测随访后的发病率为0.1％。根据这些数据，我们可以推断综合检测具有最低的CIN3发病率，因此在这种情况下，如果下一步的处理方案是为了减少患病率，可能会更倾向于选择阴性综合检测作为随访手段。但在制定具体处理方案时，仍需综合考虑患者的实际情况、医疗资源和其他因素，以制定最有效的个体化治疗方案。",
  "query": "在潜在队列研究中，某项实验证明在7年的最大随访期内，接受一次阴性细胞学随访后CIN3的发病率为0.7％，接受一次阴性HPV测试随访后的发病率为0.2％，接受阴性综合检测随访后的发病率为0.1％。你认为在这种情况下，应该如何选择下一步的处理方案呢？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在潜在队列研究中，某项实验证明在7年的最大随访期内，接受一次阴性细胞学随访后CIN3的发病率为0.7％，接受一次阴性HPV测试随访后的发病率为0.2％，接受阴性综合检测随访后的发病率为0.1％。你认为在这种情况下，应该如何选择下一步的处理方案呢？\n\n<reference text>: A prospective cohort study showed the crude rate of CIN3 was $0 .7 \\%$ following a single follow up negative cytology, $0 .2 \\%$ following a single negative follow up HPV testing and $0 .1 \\%$ following a negative follow up co-testing in women with HPV-positive ASCUS or any LSIL and less than CIN2 on colposcopy or biopsy over a maximum of 7 years follow up (64).\n\n<reply>: ",
  "response": "基于潜在队列研究的结果，在接受一次阴性细胞学随访后，CIN3的发病率为0.7％；接受一次阴性HPV测试随访后的发病率为0.2％；而接受阴性综合检测随访后的发病率为0.1％。根据这些数据，我们可以推断综合检测具有最低的CIN3发病率，因此在这种情况下，如果下一步的处理方案是为了减少患病率，可能会更倾向于选择阴性综合检测作为随访手段。但在制定具体处理方案时，仍需综合考虑患者的实际情况、医疗资源和其他因素，以制定最有效的个体化治疗方案。"
}